Visual evoked potentials in neuromyelitis optica and its spectrum disorders

Multiple Sclerosis Journal

Volumn 20, Issue 5, 2014, Pages 617-620

  Ringelstein, Marius ^a   Kleiter, Ingo ^b   Ayzenberg, Ilya ^b   Borisow, Nadja ^c   Paul, Friedemann ^c   Ruprecht, Klemens ^c   Kraemer, Markus ^d   Cohn, Eva ^a   Wildemann, Brigitte ^e   Jarius, Sven ^e   Hartung, Hans Peter ^a   Aktas, Orhan ^a   Albrecht, Philipp ^a  

^a HEINRICH HEINE UNIVERSITY   (Germany)

^b ST JOSEF HOSPITAL   (Germany)

^c CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

^d ALFRIED KRUPP KRANKENHAUS   (Germany)

^e UNIVERSITY OF HEIDELBERG   (Germany)

Author keywords

Aquaporin 4 antibody; neuromyelitis optica; neuromyelitis optica spectrum disorders; optic neuritis; P100 latency; visual evoked potential

Indexed keywords

AQUAPORIN 4 ANTIBODY; AQP4 PROTEIN, HUMAN; AQUAPORIN 4; AUTOANTIBODY; BIOLOGICAL MARKER;

ADULT; ARTICLE; CAUCASIAN; CLINICAL ARTICLE; CONTROLLED STUDY; EVOKED VISUAL RESPONSE; FEMALE; HUMAN; LATENT PERIOD; MALE; MEDICAL RECORD REVIEW; MYELOOPTIC NEUROPATHY; RETROSPECTIVE STUDY; BLOOD; CLINICAL TRIAL; ETHNOLOGY; GERMANY; IMMUNOLOGY; MIDDLE AGED; MULTICENTER STUDY; NEUROMYELITIS OPTICA; PATHOPHYSIOLOGY; REACTION TIME; TIME; YOUNG ADULT; COHORT ANALYSIS; EYE DISEASE ASSESSMENT; NEUROMYELITIS OPTICA SPECTRUM DISORDER; OPTIC NERVE DISEASE; VISUAL STIMULATION; VISUAL SYSTEM FUNCTION;

ADULT; AQUAPORIN 4; AUTOANTIBODIES; BIOLOGICAL MARKERS; EUROPEAN CONTINENTAL ANCESTRY GROUP; EVOKED POTENTIALS, VISUAL; FEMALE; GERMANY; HUMANS; MALE; MIDDLE AGED; NEUROMYELITIS OPTICA; REACTION TIME; RETROSPECTIVE STUDIES; TIME FACTORS; YOUNG ADULT;

EID: 84895072876     PISSN: 13524585     EISSN: 14770970     Source Type: Journal    
DOI: 10.1177/1352458513503053     Document Type: Article

References (10)

1. Wingerchuk DM, Lennon VA, Lucchinetti CF, et al. The spectrum of neuromyelitis optica. Lancet Neurol. 2007 ; 6: 805-815
2. Halliday AM, McDonald WI, Mushin J. Delayed visual evoked response in optic neuritis. Lancet. 1972 ; 1: 982-985
3. Halliday AM, McDonald WI, Mushin J. Visual evoked response in diagnosis of multiple sclerosis. Br Med J. 1973 ; 4: 661-664
4. Neto SP, Alvarenga RM, Vasconcelos CC, et al. Evaluation of pattern-reversal visual evoked potential in patients with neuromyelitis optica. Mult Scler. 2013 ; 19: 173-178
5. Wingerchuk DM, Lennon VA, Pittock SJ, et al. Revised diagnostic criteria for neuromyelitis optica. Neurology. 2006 ; 66: 1485-1489
6. Odom JV, Bach M, Brigell M, et al. ISCEV standard for clinical visual evoked potentials (2009 update). Doc Ophthalmol. 2010 ; 120: 111-119
7. Kurtzke JF. Rating neurologic impairment in multiple sclerosis: An Expanded Disability Status Scale (EDSS). Neurology. 1983 ; 33: 1444-1452
8. Jarius S, Probst C, Borowski K, et al. Standardized method for the detection of antibodies to aquaporin-4 based on a highly sensitive immunofluorescence assay employing recombinant target antigen. J Neurol Sci. 2010 ; 291: 52-56
9. Jarius S, Ruprecht K, Wildemann B, et al. Contrasting disease patterns in seropositive and seronegative neuromyelitis optica: A multicentre study of 175 patients. J Neuroinflamm. 2012 ; 9: 14
10. Matthews WB, Small DG, Small M, et al. Pattern reversal evoked visual potential in the diagnosis of multiple sclerosis. J Neurol Neurosurg Psychiatry. 1977 ; 40: 1009-1014